论文部分内容阅读
尽管主动脉夹层(AD)在临床上不常见,但其发病凶险,许多患者死于院外或未明确诊断,约有1/3的患者表现为受累系统器官的症状。有些患者无发病体征,即使有体征,也是复杂多样的。临床上应高度警惕,以便对AD作出快速、准确的诊断。AD的治疗主要包括积极控制血压、外科手术。近年来,血管腔内治疗用于治疗AD已取得了大量理论和实践上的临床经验,其微创优势已被证实。但国外主动脉夹层发病率低,血管腔内治疗的近远期疗效仍需进一步研究评价。未来的发展主要体现在器材创新方面,使解剖复杂尤其是需要杂交技术完成的夹层得到更加合理的治疗。
Although aortic dissection (AD) is clinically uncommon, it is an extremely dangerous disease, with many patients dying out of hospital or without a clear diagnosis. About one-third of patients experience symptomatic organ involvement. Some patients without signs of disease, even if there are signs, but also complex and diverse. Clinic should be highly vigilant in order to make a quick and accurate diagnosis of AD. AD treatment includes active control of blood pressure, surgery. In recent years, endovascular therapy for the treatment of AD has made a lot of theoretical and practical clinical experience, its minimally invasive advantages have been confirmed. However, the incidence of aortic dissection abroad is low, the short-term efficacy of endovascular treatment needs further study and evaluation. The future development is mainly reflected in the equipment innovation, so that the anatomical complexity, especially the need to complete the hybridization of the interlayer to be more reasonable treatment.